{
	"POTX_news": [
		{
			"stock": "TLRY",
			"news_titles": [
				"Analyst Report: Tilray Brands, Inc.",
				"Is TLRY Stock A Buy After Feds Recommend Cannabis To Be Rescheduled?",
				"HHS officials recommend the DEA ease its marijuana restrictions",
				"Why Tilray Stock Surged Today",
				"Tilray and Curaleaf Stocks Surge as DEA Considers Reclassifying Marijuana",
				"Canadian Investment Regulatory Organization Trade Resumption - TLRY",
				"Canadian Investment Regulatory Organization Trading Halt - TLRY",
				"3 Key Tests for Tilray Stock in Fall 2023"
			]
		},
		{
			"stock": "ACB",
			"news_titles": [
				"Analyst Report: Aurora Cannabis Inc.",
				"HHS officials recommend the DEA ease its marijuana restrictions",
				"This F-Rated Cannabis Stock Is One of the Worst Companies You Could Buy Now",
				"3 Cannabis Stocks to Snap Up Before They Skyrocket",
				"Aurora Cannabis Announces Results of 2023 Annual General Meeting",
				"Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA",
				"QuidelOrtho (QDEL) Beats Q2 Earnings and Revenue Estimates",
				"Estimating The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)"
			]
		},
		{
			"stock": "SNDL",
			"news_titles": [
				"SNDL and Nova Cannabis Extend Outside Date for Closing of the Strategic Partnership",
				"2 Cannabis Stocks That Have Turned to Alcohol for Growth",
				"The 3 Most Undervalued Cannabis Stocks to Buy Now: August 2023",
				"SNDL Reports Second Quarter 2023 Financial and Operational Results",
				"3 Budding Cannabis Stocks to Buy Now",
				"20 Cities with the Cheapest Weed in the World",
				"SNDL to Announce Second Quarter 2023 Financial Results on August 14, 2023",
				"SNDL Announces 2023 Annual General Meeting Results"
			]
		},
		{
			"stock": "MAPS",
			"news_titles": [
				"Weedmaps and \"The Freak Brothers\" Get Lit for Season 2",
				"WM Technology, Inc. Reports Second Quarter 2023 Financial Results",
				"WM Technology, Inc. Announces Second Quarter 2023 Financial Results Conference Call"
			]
		},
		{
			"stock": "MYMD",
			"news_titles": [
				"FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA)",
				"MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results",
				"MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty"
			]
		}
	]
}